Join Now

Category Archives: BioUtah News

Mountain Pacific Partners Invests $2M in Growth Capital into Alterra Medical

Salt Lake City-based specialty medical device distributor is poised for value-creating diversification and supply chain innovation.

| Tagged , | Leave a comment

Alterra Medical Announces Jeff Hastings as New Chief Executive Officer

With more than two decades of healthcare expertise, Hastings brings track record of leading transformative growth.

| Tagged | Leave a comment

ARUP’s Investment Will Help Boost Development of Techcyte’s AI-Enabled Diagnostics Platform

ARUP Laboratories recently announced an investment in Techcyte Inc. as part of the Orem, Utah-based company’s new $21 million funding round.

| Tagged , | Leave a comment

ANNUAL BIOUTAH AWARDS

Nominations are now open for BioUtah’s 2021 awards. The deadline for nominations is September 18.

| Tagged | Leave a comment

KNOWN MEDICINE RAISES $7.2 MILLION SEED ROUND TO ADVANCE DATA FIRST APPROACH TO ORGANOID TECHNOLOGY

Known Medicine today announced the closure of its seed round of funding in the amount of $7.2 million led by Caffeinated Capital, with participation from Khosla Ventures, Cota Capital, Kickstart, Forward VC, OATV, Y Combinator and noted angel investors Chris Gibson, CEO & Co-Founder at Recursion Pharmaceuticals, Nish Bhat, previously Co-Founder at Color Genomics, and others.

| Tagged | Leave a comment

Fluidx Medical Technology’s Innovative Embolic Tumor Treating Device Highlighted in “BEST of GEST” Session at the Global Embolization Oncology Symposium Technologies (“GEST”) Conference

Fluidx Medical’s GPX™ Embolic Device Use for Tumor Treatments Chosen for “BEST of GEST” Embolization Program at the Annual GEST Meeting.

| Tagged , | Leave a comment

ZIEN Medical Technologies is Expanding

ZIEN Medical Technologies, of Salt Lake City, Utah, announces the integration of Eclipse Design Innovations, of Woods Cross, Utah, as well as the Grand Opening of their new 16,000 sq foot manufacturing/R&D facility to continue to support the Utah Life Sciences industry. 

| Tagged | Leave a comment

Payer Budget Impact Analysis Projects Significant Savings from KidneyIntelXTM Testing at Primary Care Level

Renalytix Plc announced the publication of results from an external chronic kidney disease budget impact analysis projecting 5-year savings of $1.1 billion dollars for a population of 100,000 patients with type 2 diabetes (T2DKD) and chronic kidney disease tested with the Renalytix KidneyIntelX™ testing solution. Savings were driven by more effective pharmacy management and appropriate specialist referral compared to current standard of care for patients at high risk for disease progression and kidney failure.

| Leave a comment

PolarityTE Provides Update on U.S. FDA Investigational New Drug Application for SkinTE®

PolarityTE, Inc. today provided an update regarding correspondence from the U.S. Food and Drug Administration (FDA) related to its Investigational New Drug Application (IND) for SkinTE® with a proposed indication for chronic cutaneous ulcers, which was filed on July 23, 2021.

| Tagged | Leave a comment

Perfect Day To Expand Bio Foundry Capabilities in Utah

The Utah Governor’s Office of Economic Opportunity (Go Utah) is pleased to announce that Perfect Day, Inc. is formally expanding its “biology-as-a-service” arm, Scalable Bio Foundry, Inc. (SBF, Inc.) in Utah, bringing up to 64 new high-paying jobs to the state in the next five years.

| Tagged , , , | Leave a comment

Javara and Ogden Clinic launch partnership to advance clinical trial access

Javara and Ogden Clinic are proud to announce the launch of a partnership to integrate industry-sponsored clinical trials at the point of care for Ogden Clinic patients.

| Tagged , | Leave a comment

VIA CAPITAL announces the launch of Tailwind Business Accelerator

Tailwind Business Accelerator is giving $50,000 in cash and services to at least 5 companies in its first cohort, starting November 1. Applications close September 17 for this first cohort.

| Tagged , | Leave a comment